|
|
Volumn 71 Suppl E1, Issue , 2010, Pages
|
|
Rationale for, barriers to, and appropriate medication for the long-term treatment of depression.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
ANXIETY DISORDER;
CHRONIC DISEASE;
COGNITIVE THERAPY;
COMORBIDITY;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
DRUG COMBINATION;
HEALTH CARE DELIVERY;
HUMAN;
LONG TERM CARE;
MAJOR DEPRESSION;
MULTIMODALITY CANCER THERAPY;
PATIENT COMPLIANCE;
PSYCHOLOGICAL ASPECT;
RECURRENT DISEASE;
ANTIDEPRESSIVE AGENTS;
ANXIETY DISORDERS;
BENZODIAZEPINES;
CHRONIC DISEASE;
COGNITIVE THERAPY;
COMBINED MODALITY THERAPY;
COMORBIDITY;
DEPRESSIVE DISORDER, MAJOR;
DRUG THERAPY, COMBINATION;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
LONG-TERM CARE;
MEDICATION ADHERENCE;
RECURRENCE;
|
|
EID: 77951225515
PISSN: None
EISSN: 15552101
Source Type: Journal
DOI: 10.4088/JCP.8001tx16c Document Type: Conference Paper |
|
Times cited : (21)
|
|
References (38)
|
